Clinical Trial Update: Safety and Efficacy of THN102 on Sleepiness in Narcoleptic Patients [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating THN102 for safety and efficacy in reducing sleepiness in narcolepsy patients has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Narcolepsy

Drugs mentioned

• THN102

Snippet

Sponsor: Theranexus | Conditions: Narcolepsy | Phase 2 | Status: COMPLETED | Results posted: 2020-09-04